Provenance Wealth Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12
| Closed | -$1.33K | – | 505 |
|
|
2025
Q1 | $1.33K | Hold |
12
| – | – | ﹤0.01% | 442 |
|
|
2024
Q4 | $1.64K | Hold |
12
| – | – | ﹤0.01% | 442 |
|
|
2024
Q3 | $1.38K | Hold |
12
| – | – | ﹤0.01% | 503 |
|
|
2024
Q2 | $1.65K | Hold |
12
| – | – | ﹤0.01% | 392 |
|
|
2024
Q1 | $1.66K | Hold |
12
| – | – | ﹤0.01% | 428 |
|
|
2023
Q4 | $1.58K | Hold |
12
| – | – | ﹤0.01% | 485 |
|
|
2023
Q3 | $1.35K | Buy |
+12
| New | +$1.35K | ﹤0.01% | 364 |
|